Markets:

Overview

News

Currencies

International

Treasuries

Articles published by Iambic

Iambic Launches Enchant v3 – Molecular Superintelligence Designed to Advance End-to-End Drug Discovery & Development

September 21, 2026

From Iambic

Via Business Wire

Iambic Named to CNBC Disruptor 50 for Second Consecutive Year

May 19, 2026

From Iambic

Via Business Wire

Iambic to Participate in Upcoming Investor Conferences

May 11, 2026

From Iambic

Via Business Wire

Iambic to Participate in April Investor Conferences

April 02, 2026

From Iambic

Via Business Wire

Iambic to Participate in March Investor Conferences

March 02, 2026

From Iambic

Via Business Wire

Iambic Announces Collaboration with Takeda to Advance AI-Driven Design of Small Molecules

February 09, 2026

From Iambic

Via Business Wire

Iambic Raises Over $100 Million in an Oversubscribed Round to Advance Its Portfolio of AI-Discovered Therapeutics and Leading Platform Technologies

November 10, 2025

From Iambic

Via Business Wire

Iambic to Participate in November Investor Conferences

November 04, 2025

From Iambic

Via Business Wire

Iambic Announces Enchant v2, its Next Generation AI Model for Predicting the Clinical Viability of Drug Discovery Programs

May 05, 2025

From Iambic

Via Business Wire

Iambic to Participate in Upcoming Investor Conferences

March 25, 2025

From Iambic

Via Business Wire

Iambic to Participate in Upcoming Investor Conferences

March 03, 2025

From Iambic

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.